Noile-Immune Biotech Overview
- Year Founded
-
2015
- Status
-
Public
- Employees
-
28
- Stock Symbol
-
4893
- Share Price
-
$0.48
- (As of Wednesday Closing)
Noile-Immune Biotech General Information
Description
Noile-Immune Biotech Inc is engaged in the development of CAR-T cell therapy for solid cancers using its proprietary technology. The company's development pipeline and collaborative projects with other companies include different product candidates such as NIB102, NIB103, NIB104, ADAP01, AUTL01, etc. It operates in a single segment, the cancer immunotherapy drug discovery business.
Contact Information
Website
www.noile-immune.comCorporate Office
- 2-12-10 Shibadaimon 2-chome, Minato-ku
- T&G Hamamatsucho Building 5F
- Tokyo, 105-0012
- Japan
Corporate Office
- 2-12-10 Shibadaimon 2-chome, Minato-ku
- T&G Hamamatsucho Building 5F
- Tokyo, 105-0012
- Japan
Noile-Immune Biotech Stock Performance
As of 18-Nov-2026, Noile-Immune Biotech’s stock price is $0.48. Its current market cap is $20.9M with 43.4M shares.
(As of Wednesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.48 | $0.51 | $0.48 - $1.36 | $20.9M | 43.4M | 219K | -$0.11 |
Noile-Immune Biotech Financials Summary
As of 30-Jun-2026, Noile-Immune Biotech has a trailing 12-month revenue of $4.63K.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 9,238 | 10,515 | 15,289 | 24,872 |
| Revenue | 5 | 33 | 50 | 2,255 |
| Net Income | (4,882) | (5,302) | (6,368) | (8,042) |
| Total Assets | 22,632 | 25,645 | 30,568 | 40,977 |
| Total Debt | 0 | 0 | 0 | 0 |
Noile-Immune Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Noile-Immune Biotech Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Noile-Immune Biotech Comparisons
Industry
Financing
Details
Noile-Immune Biotech Competitors (2)
One of Noile-Immune Biotech’s 2 competitors is Elpiscience Biopharmaceuticals, a Venture Capital-Backed company based in Shanghai, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Elpiscience Biopharmaceuticals | Venture Capital-Backed | Shanghai, China | ||||
| Abbisko Medicine | Formerly VC-backed | Shanghai, China |
Noile-Immune Biotech Patents
Noile-Immune Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026121219-A1 | Method for producing genetically modified immunocompetent cells | Pending | 03-Dec-2024 | ||
| EP-4382539-A1 | Antibody binding to linker of scfv or like | Inactive | 02-Aug-2021 | ||
| US-20240400718-A1 | Antibody binding to linker of scfv or like | Pending | 02-Aug-2021 | ||
| WO-2023013619-A1 | Antibody binding to linker of scfv or like | Inactive | 02-Aug-2021 | ||
| CA-3225682-A1 | Anti-egfrviii antibody, polypeptide, cell capable of expressing said polypeptide, pharmaceutical composition comprising said cell, method for producing said cell, and polynucleotide or vector comprising nucleotide sequence encoding said polypeptid | Pending | 16-Jul-2021 | A61K40/11 |
Noile-Immune Biotech Signals
Noile-Immune Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Noile-Immune Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Noile-Immune Biotech FAQs
-
When was Noile-Immune Biotech founded?
Noile-Immune Biotech was founded in 2015.
-
Where is Noile-Immune Biotech headquartered?
Noile-Immune Biotech is headquartered in Tokyo, Japan.
-
What is the size of Noile-Immune Biotech?
Noile-Immune Biotech has 28 total employees.
-
What industry is Noile-Immune Biotech in?
Noile-Immune Biotech’s primary industry is Drug Discovery.
-
Is Noile-Immune Biotech a private or public company?
Noile-Immune Biotech is a Public company.
-
What is Noile-Immune Biotech’s stock symbol?
The ticker symbol for Noile-Immune Biotech is 4893.
-
What is the current stock price of Noile-Immune Biotech?
As of 18-Nov-2026 the stock price of Noile-Immune Biotech is $0.48.
-
What is the current market cap of Noile-Immune Biotech?
The current market capitalization of Noile-Immune Biotech is $20.9M.
-
What is Noile-Immune Biotech’s current revenue?
The trailing twelve month revenue for Noile-Immune Biotech is $4.63K.
-
Who are Noile-Immune Biotech’s competitors?
Elpiscience Biopharmaceuticals and Abbisko Medicine are competitors of Noile-Immune Biotech.
-
What is Noile-Immune Biotech’s annual earnings per share (EPS)?
Noile-Immune Biotech’s EPS for 12 months was -$0.11.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process